Neuronetics
STIM • NASDAQ
Neuronetics is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Stephen J. Furlong, with a market cap of $89.4M.
CEOStephen J. Furlong
Next Earnings
Upcoming earnings announcement for Neuronetics
Date
Tuesday, May 5, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.17
Revenue Estimate
$34.2M
Earnings History
Past 12 earnings reports for Neuronetics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.10Est: -$0.11 | +9.1% | $41.8MEst: $40.8M | +2.3% |  10-K |
| Nov 4, 2025 | Q3 2025 | -$0.13Est: -$0.12 | -8.3% | $37.3MEst: $38.0M | -1.8% | 10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.15Est: -$0.08 | -87.5% | $38.1MEst: $36.8M | +3.4% | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.21Est: -$0.12 | -75.0% | $32.0MEst: $29.1M | +10.0% | 10-Q |
| Mar 4, 2025 | Q4 2024 | -$0.33Est: -$0.24 | -37.5% | $22.5MEst: $19.0M | +18.5% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.29Est: -$0.23 | -26.1% | $18.5MEst: $19.1M | -3.1% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.33Est: -$0.27 | -22.2% | $16.5MEst: $18.7M | -11.8% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.27Est: -$0.31 | +12.9% | $17.4MEst: $17.1M | +1.7% | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$0.19Est: -$0.26 | +26.9% | $20.3MEst: $19.9M | +2.3% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.33Est: -$0.31 | -6.5% | $17.9MEst: $17.6M | +1.7% | — |
| Aug 8, 2023 | Q2 2023 | -$0.17Est: -$0.35 | +51.4% | $17.6MEst: $17.4M | +1.3% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.38Est: -$0.39 | +2.6% | $15.5MEst: $15.2M | +2.4% | — |